Skip to search formSkip to main contentSkip to account menu

DIRECT ACTING ANTIVIRALS

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
The increasing worldwide prevalence of Hepatocellular carcinoma (HCC), characterized by resistance to conventional chemotherapy… 
2019
2019
A community‐based public health facility in Sydney, Australia, the Kirketon Road Centre (KRC), provides health care to people who… 
Highly Cited
2017
Highly Cited
2017
Direct acting antivirals (DAAs) have revolutionized hepatitis C (HCV) treatment with >90% cure rates even in real‐world studies… 
Review
2017
Review
2017
ABSTRACT Introduction: Hepatitis C virus (HCV) represents a major health concern, as nearly 3 million people become newly… 
Review
2016
Review
2016
Over the past two decades, ribavirin has been an integral component of treatment for hepatitis C virus (HCV) infection, where it… 
Highly Cited
2015
Highly Cited
2015
Broad-spectrum antiviral drugs are under development to treat emerging viral diseases such as Ebola and dengue for which no… 
Review
2014
Review
2014
In recent years, several studies have clearly shown that sustained virological response (SVR) achieved by interferon‐based… 
Review
2013
Review
2013
The current treatment for hepatitis C virus (HCV) genotype 1 chronic infection is the addition of direct‐acting antivirals (DAA…